This document (March 2021) is a tool to help guide stakeholder engagement in COVID-19 research. Built from the Good Participatory Practice Guidelines for Biomedical HIV Prevention Trials (GPP), this new document responds to needs expressed by both researchers and advocates as the world watched COVID-19 research progress with unprecedented speed and urgency.
Find out more and download the Essential Principles & Practices tool HERE
This article is part of our theme area on Good Participatory Practice in COVID-19 Research
This work is licensed under a Creative Commons Attribution 4.0 International License